Search

Supreme Court to Decide Fate of Thousands of Roundup Cancer Lawsuits

The Supreme Court announced last week that it will hear Monsanto’s claim that it should be shielded from tens of thousands of lawsuits over Roundup because the Environmental Protection Agency (EPA) has not required a warning label that the weedkiller may cause cancer. This court decision could effectively curtail one of the largest waves of tort litigation in American history, with far-reaching implications for consumers, farmers, and the agricultural industry.

The Issue the Supreme Court Must Rule On

The Supreme Court will examine whether federal law preempts state-level failure-to-warn claims against Roundup–maker Monsanto, now owned by Bayer. At the heart of this legal battle is the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), which governs pesticide regulation in the United States. Bayer argues that since the EPA has repeatedly approved Roundup’s label without requiring cancer warnings, the company should be protected from state lawsuits alleging inadequate warnings.

The Roundup cancer lawsuit that prompted this Supreme Court review involves John Durnell, a Missouri resident who allegedly developed non-Hodgkin’s lymphoma after years of using Roundup in community gardens. A jury awarded him $1.25 million in damages after finding Monsanto liable for failing to warn about potential cancer risks.

Scientific Controversy Surrounding Glyphosate Exposure

While the Supreme Court won’t directly address the issue of whether Roundup weedkiller causes cancer, the scientific debate forms the backdrop of this legal battle. Glyphosate, Roundup’s active ingredient, has been the subject of conflicting scientific assessments over the years.

In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.” This determination sparked thousands of Roundup lawsuits against Monsanto. However, the EPA has consistently maintained that glyphosate does not pose a cancer risk when used according to label directions.

Adding to the controversy, a scientific journal recently retracted a widely cited paper that had declared glyphosate safe. The retraction came after emails revealed in litigation suggested Monsanto scientists had guided the research, raising questions about the independence of scientific evaluations used by regulatory agencies.

The Financial Stakes for Bayer

The financial implications of this Roundup lawsuit review are enormous. Bayer has already paid out more than $10 billion to settle approximately 100,000 Roundup claims and faces thousands more. A ruling in Bayer’s favor could potentially save the company billions by allowing it to dismiss many pending Roundup cancer lawsuits. It could also establish a precedent, making it more difficult to hold manufacturers accountable when federal agencies approve their products. 

Beyond Roundup itself, the Supreme Court’s decision could reshape how courts handle conflicts between federal regulators and state consumer protection laws. If the Supreme Court sides with Bayer, it may narrow the ability of states to enforce their own warning requirements when federal agencies approve product labels. That shift would affect not only pesticides but also pharmaceuticals, household chemicals, and other regulated products, limiting the role of juries in weighing evidence that emerges after federal approval. 

Legal scholars say the ruling could redefine where regulatory authority ends and corporate liability begins, changing how future injury claims are litigated across the country.

What Happens Next?

The Supreme Court will likely hear arguments in the Roundup lawsuit review in April and issue a ruling by late June. The court’s decision could either preserve the ability of individuals to seek compensation for alleged Roundup-related injuries, like cancer, or effectively end most pending litigation against Bayer.

Whatever the outcome, this review highlights the complex intersection of science, regulation, and law in addressing potential public health risks. As this landmark claim moves forward, it serves as a reminder of the importance of vigilance regarding product safety and the ongoing need for transparent, independent scientific assessment of chemicals widely used in our food system.

Roundup Lawsuit Information

Roundup lawsuits are alleging a link between the glyphosate-based weed killer and an increased risk of cancer and other adverse human health outcomes. Learn more by clicking on the button.
FREE
author avatar
Faith Anderson Investigative Journalist
Faith Anderson is an investigative journalist and consumer advocate with over 15 years at LeadingJustice.net. A UNC Wilmington alumna, she writes to empower individuals harmed by corporate negligence. Faith lives full-time in Puerto Rico, where her husband volunteers with the Puerto Rico Dog Fund, and she frequently travels across the U.S. to investigate claims. When not reporting, she’s surfing or spending time in nature with her rescue dogs.
Facebook
Twitter
Pinterest
LinkedIn
Reddit
WhatsApp

Related Posts

Bayer Proposes $7.25 Billion Settlement for Glyphosate-Related Cancer Claims

Roundup manufacturer Monsanto, now owned by Bayer AG, recently submitted a comprehensive $7.25 billion tiered settlement proposal through the Circuit Court in St. Louis, Missouri. The agreement aims to resolve thousands of pending civil claims brought by individuals who allege that they developed cancer from exposure to glyphosate in Roundup.

Roundup Weed Killer Ingredient Found in Popular Bread Brands: What You Need to Know

Recent findings from Florida’s “Healthy Florida First” initiative have raised concerns about the presence of glyphosate, a widely used herbicide, in popular bread brands. Glyphosate, the active ingredient in Roundup weed killer products, is primarily used in the agricultural industry to eliminate unwanted plants. However, its presence in everyday food

Journal Retracts Key Study Claiming Roundup Doesn’t Cause Cancer

The journal Regulatory Toxicology and Pharmacology has officially retracted a pivotal scientific paper published in 2000 that supported Monsanto’s assertion that its herbicide, Roundup, and its active ingredient, glyphosate, do not pose cancer risks to humans. This retraction raises significant concerns regarding the integrity of the research and the ethical

Scroll to Top